Read on Twitter
Time for a short $ABBV THREAD
$ABBV has been a position in my portfolio for sometime now, and I continue to believe in them Long-Term
Please comment and retweet, I always enjoy hearing everyone's thoughts
THREAD
$ABBV has been a position in my portfolio for sometime now, and I continue to believe in them Long-Term
Please comment and retweet, I always enjoy hearing everyone's thoughts
THREAD
1/
This thread will be an intro for my Newsletter set to drop this week related to my research on $ABBV.
If you have not already done so, please subscribe for updates, it is FREE!!
https://roussinfinancial.substack.com/
This thread will be an intro for my Newsletter set to drop this week related to my research on $ABBV.
If you have not already done so, please subscribe for updates, it is FREE!!
https://roussinfinancial.substack.com/
2/
"What is $ABBV"
Spin-off from Abbott Labs $ABT
Became its own entity in 2013
Pharmaceutical company with the #1 selling drug in the world for the past few years, Humira
"What is $ABBV"
Spin-off from Abbott Labs $ABT Became its own entity in 2013 Pharmaceutical company with the #1 selling drug in the world for the past few years, Humira
3/
As a pharmaceutical company, they are focused on developing various drugs, which can come with added risk when those do not work out.
As I mentioned, $ABBV has the #1 selling drug in the world for the past few years called HUMIRA
As a pharmaceutical company, they are focused on developing various drugs, which can come with added risk when those do not work out.
As I mentioned, $ABBV has the #1 selling drug in the world for the past few years called HUMIRA
4/
You may have seen the commercials a time or two, but Humira is a treatment for inflammatory disease, such as rheumatoid arthritis, psoriasis, and Crohn's disease (according to the website)
You may have seen the commercials a time or two, but Humira is a treatment for inflammatory disease, such as rheumatoid arthritis, psoriasis, and Crohn's disease (according to the website)
5/
In 2019, Humira sales reached nearly $20 billion, but that was the high point as International patent protections started to roll off.
For the last 12 months, through Q3, Humira sales totaled $19.8 Billion
In 2019, Humira sales reached nearly $20 billion, but that was the high point as International patent protections started to roll off.
For the last 12 months, through Q3, Humira sales totaled $19.8 Billion
6/
In 2023, the company will lose US protection which will be a huge blow to total sales.
Why am I discussing just 1 drug so much. A few years back, this 1 drug accounted for 70% of TOTAL sales for the company.
Today, Humira accounts for roughly 46% of total sales
In 2023, the company will lose US protection which will be a huge blow to total sales.
Why am I discussing just 1 drug so much. A few years back, this 1 drug accounted for 70% of TOTAL sales for the company.
Today, Humira accounts for roughly 46% of total sales
7/
The company has diversified their portfolio over the years and has some rising blockbuster drugs as well as a loaded pipeline
The company has diversified their portfolio over the years and has some rising blockbuster drugs as well as a loaded pipeline
8/
In the past year, the company closed on their $63 Billion acquisition of Botox leader Allergan
Management expects to create $2 Billion in synergies over the next 24 months
In the past year, the company closed on their $63 Billion acquisition of Botox leader AllerganManagement expects to create $2 Billion in synergies over the next 24 months
9/
One big reason I like $ABBV is due to the fact they offer the Investor Trifecta.
High-Yield Dividends
Strong Dividend Growth
Growth potential
One big reason I like $ABBV is due to the fact they offer the Investor Trifecta. High-Yield Dividends Strong Dividend Growth Growth potential
10/
Disclaimer: This thread is for informational purposes only. I do have a position in $ABBV, but this is not a recommendation.. Please perform your own Due Diligence
Disclaimer: This thread is for informational purposes only. I do have a position in $ABBV, but this is not a recommendation.. Please perform your own Due Diligence
11/
Learn more about Dividend Stocks with my eBook "Dividend Investing: The Secret To Building Lasting Wealth"
To celebrate 11,000 FOLLOWERS, I will be selling the next 11 copies of my book for ONLY $11 https://gumroad.com/l/zoUNO/11K
Learn more about Dividend Stocks with my eBook "Dividend Investing: The Secret To Building Lasting Wealth"
To celebrate 11,000 FOLLOWERS, I will be selling the next 11 copies of my book for ONLY $11
https://gumroad.com/l/zoUNO/11K
9 copies left at ONLY $11!!
8 copies LEFT at ONLY $11!!
7 copies left for ONLY $11!!
6 copies LEFT at only $11!!
